The impact of recurrent mitral regurgitation after surgical or transcatheter mitral valve repair: a comprehensive review and a meta-analysis
Interdisciplinary CardioVascular and Thoracic Surgery · 04.06.2025 · 40 (6)
DOI: 10.1093/icvts/ivaf109 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, online erschienen am 29.04.2025. Verfasst von Chengyuan Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Heart Valve Prosthesis Implantation, Mitral Valve, Cardiac Catheterization. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND Recurrent mitral regurgitation (MR) is typically defined as MR that is moderate or severe on follow-up echocardiography after the intervention. This meta-analysis summarizes the results of all available studies on the impact of recurrent MR on clinical outcomes after the intervention. METHODS Medline, EMBASE, PubMed and Web of Science were searched from January 2000 to August 2024 for original studies reporting outcomes about the clinical impact of recurrent MR. Five clinical outcomes were analysed: reoperation, cardiovascular deaths, readmission, heart failure and New York Heart Association (NYHA) functional classification. The summary odds ratio (OR) with the 95% confidence interval (CI) was used to assess the risk of clinical outcomes. RESULTS A total of 22 studies were included in the final analysis, involving 5,804 patients, of which 960 had recurrent MR. The overall pooled incidence of recurrent MR is 16.54%. Secondary or primary patients with MR with recurrent MR after an intervention had higher rates of reoperation [(OR = 6.25, 95% CI, 2.95–14.41; P < 0.001) or (OR = 22.54, 95% CI, 14.96–33.98; P < 0.001)]or of cardiovascular death [(OR = 5.26, 95% CI, 2.35–11.77; P < 0.001) or (OR = 1.68, 95% CI, 1.32–2.14; P < 0.001)]. The rates were also high for readmission (OR = 3.95, 95% CI, 2.56–6.10; P < 0.001), heart failure incidence (OR = 2.87, 95% CI, 1.75–5.11; P < 0.001) and the number of NYHA functional class III/IV (OR = 5.40, 95% CI, 3.01–9.70; P < 0.001) for recurrent MR of secondary MR. However, no significant association was found between recurrent MR of primary MR and the incidence of NYHA functional class III/IV (OR = 1.02, 95% CI, 0.47–2.22; P = 0.96). CONCLUSIONS Recurrent MR is associated with higher rates of reoperations, readmissions, cardiovascular deaths, incidences of heart failure and NYHA functional class III/IV numbers. However, recurrent MR of primary MR is not correlated with NYHA functional class III/IV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.
- Medical Sciences Division, University of Oxford, Oxford, UK.
ORCID-Profile: Chengyuan Yu, Peyman Sardari Nia
Zitieren
APA
Yu, C., Arjomandi Rad, A., He, H., Yang, Y., Maessen, J. G., & Sardari Nia, P. (2025). The impact of recurrent mitral regurgitation after surgical or transcatheter mitral valve repair: a comprehensive review and a meta-analysis. Interdisciplinary CardioVascular and Thoracic Surgery, 40(6). https://doi.org/10.1093/icvts/ivaf109
Vancouver
Yu C, Arjomandi Rad A, He H, Yang Y, Maessen JG, Sardari Nia P. The impact of recurrent mitral regurgitation after surgical or transcatheter mitral valve repair: a comprehensive review and a meta-analysis. Interdisciplinary CardioVascular and Thoracic Surgery. 2025;40(6). doi:10.1093/icvts/ivaf109
BibTeX
@article{Yu2025,
author = {Yu, Chengyuan and Arjomandi Rad, Arian and He, Hongbo and Yang, Yichen and Maessen, Jos G and Sardari Nia, Peyman},
title = {The impact of recurrent mitral regurgitation after surgical or transcatheter mitral valve repair: a comprehensive review and a meta-analysis},
journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
year = {2025},
volume = {40},
number = {6},
doi = {10.1093/icvts/ivaf109}
}
EUVIMED